home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Thermo Fisher Scientific (NY:TMO)

469.21 -9.75 (-2.04%)

Official Closing Price Updated: 7:00 PM EDT, May 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

33 34 Next >

Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech ↗

February 15, 2024

Bridgewater Associates, founded by Ray Dalio, made notable changes to its portfolio in Q4 2023. New bets, exits, increased stakes offer insights into its investment strategy.

Via Benzinga

Buy the Dip: 3 Oversold Stocks Poised for Big Gains ↗

February 15, 2024

Discover how these oversold stocks to buy point towards potential fast gains while their fundamentals support potentially further growth.

Via InvestorPlace

TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades' ↗

February 08, 2024

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $15,000 Today ↗

February 06, 2024

Via Benzinga

Thermo Fisher Scientific: Q4 Earnings Insights ↗

January 31, 2024

Via Benzinga

A Preview Of Thermo Fisher Scientific's Earnings ↗

January 30, 2024

Via Benzinga

Market Whales and Their Recent Bets on TMO Options ↗

January 26, 2024

Via Benzinga

Breaking Down Thermo Fisher Scientific: 5 Analysts Share Their Views ↗

January 24, 2024

Via Benzinga

RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know ↗

February 01, 2024

Via Benzinga

Biotech And Medtech Portfolio Notes On A Fed Day ↗

January 31, 2024

The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%

Via Talk Markets

Topics Economy

Buy Alert: 3 Stocks Sitting in the Sweet Spot ↗

January 31, 2024

They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.

Via InvestorPlace

Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday? ↗

January 31, 2024

Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting.

Via Benzinga

Topics Economy Stocks

Peering Into Thermo Fisher Scientific's Recent Short Interest ↗

January 09, 2024

Via Benzinga

Thermo Fisher Scientific Inc. (NYSE: TMO) is a Leading Gainer in 1/9 Morning Trading

January 09, 2024

Via Investor Brand Network

Thermo Fisher Scientific (TMO) Q4 2023 Earnings Call Transcript ↗

January 31, 2024

TMO earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook ↗

January 31, 2024

"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance.

Via Benzinga

Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser ↗

January 31, 2024

The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook.

Via Benzinga

Topics Economy

Thermo Fisher Scientific Unusual Options Activity ↗

January 04, 2024

Via Benzinga

Three Stocks To Diversify Beyond The Magnificent Seven In 2024 ↗

January 03, 2024

Via Talk Markets

Earnings Scheduled For January 31, 2024 ↗

January 31, 2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.

Via Benzinga

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results

January 31, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

Via FinancialNewsMedia

$100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today ↗

January 23, 2024

Via Benzinga

Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

January 30, 2024

From FN Media Group LLC

Via GlobeNewswire

Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

January 04, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism? ↗

January 29, 2024

An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.

Via Benzinga

Topics Artificial Intelligence

Here's How Much $1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today ↗

January 03, 2024

Via Benzinga

Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024

January 03, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2024

January 02, 2024

From Thermo Fisher Scientific Inc.

Via Business Wire

Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment ↗

December 30, 2023

At this juncture, the promising proteomics market is too small to be a surefire investment.

Via The Motley Fool

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

33 34 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com